Namyangju, South Korea

Yin Mi Lee

This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Oriental Medicine. Active years: 2011.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yin Mi Lee in Diabetic Complications Treatment.

Introduction

Yin Mi Lee is an accomplished inventor based in Namyangju, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of diabetic complications. His innovative approach combines traditional herbal remedies with modern extraction techniques.

Latest Patents

Yin Mi Lee holds a patent for a method of treating diabetic complications. The patent describes a process that involves administering an extract obtained by crashing and drying selected herbs, including Euphorbiae radix, gingeredbark, parched Puerariae radix, and Glycyrrhizae radix. The dried herbal material is then extracted using alcohol or an aqueous alcohol solution, filtered, and concentrated under reduced pressure. This method aims to provide an effective treatment for individuals suffering from diabetic complications. He has 1 patent to his name.

Career Highlights

Yin Mi Lee is affiliated with the Korea Institute of Oriental Medicine, where he conducts research and develops innovative treatments. His work emphasizes the integration of traditional medicine with contemporary scientific methods, showcasing the potential of herbal remedies in modern healthcare.

Collaborations

Yin Mi Lee collaborates with notable colleagues, including Jin Sook Kim and Sang Won Lee. Their combined expertise enhances the research and development of effective treatments for various health conditions.

Conclusion

Yin Mi Lee's contributions to the treatment of diabetic complications highlight the importance of innovation in medicine. His work exemplifies the potential of combining traditional practices with modern techniques to improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…